|
ZNF169 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.37579947434574E-11 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.87399995521531E-09 |
| Normal-vs-Stage2 |
3.402900E-04 |
| Normal-vs-Stage3 |
2.43669999999696E-05 |
| Normal-vs-Stage4 |
1.456410E-03 |
| Stage1-vs-Stage2 |
4.819400E-01 |
| Stage1-vs-Stage3 |
8.075000E-01 |
| Stage1-vs-Stage4 |
7.004000E-01 |
| Stage2-vs-Stage3 |
4.446000E-01 |
| Stage2-vs-Stage4 |
4.286800E-01 |
| Stage3-vs-Stage4 |
8.821000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.20820078573092E-11 |
| Normal-vs-AfricanAmerican |
5.536400E-03 |
| Normal-vs-Asian |
3.38429284596486E-12 |
| Caucasian-vs-AfricanAmerican |
5.391400E-01 |
| Caucasian-vs-Asian |
1.234140E-02 |
| AfricanAmerican-vs-Asian |
4.121400E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.32399999747324E-08 |
| Normal-vs-Female |
7.79429853992042E-11 |
| Male-vs-Female |
1.088160E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.293700E-02 |
| Normal-vs-Age(41-60Yrs) |
1.67490021851791E-10 |
| Normal-vs-Age(61-80Yrs) |
3.20980000023674E-07 |
| Normal-vs-Age(81-100Yrs) |
8.563800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.295000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.424600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.362000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.096800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.088800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.903400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.802900E-03 |
| Normal-vs-Grade 2 |
5.49659984194761E-10 |
| Normal-vs-Grade 3 |
1.49659999948426E-07 |
| Normal-vs-Grade 4 |
2.698200E-02 |
| Grade 1-vs-Grade 2 |
9.420300E-02 |
| Grade 1-vs-Grade 3 |
4.142100E-02 |
| Grade 1-vs-Grade 4 |
1.936260E-02 |
| Grade 2-vs-Grade 3 |
3.770200E-01 |
| Grade 2-vs-Grade 4 |
7.378000E-02 |
| Grade 3-vs-Grade 4 |
2.376800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.62501173312558E-13 |
| Normal-vs-ccB subtype |
9.53179999999554E-05 |
| ccA subtype-vs-ccB subtype |
2.673800E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.64750041071238E-10 |
| Normal-vs-N1 |
9.384000E-02 |
| N0-vs-N1 |
7.810000E-01 |
|
|
